The germline inactivating variants in the primary MMR genes (MSH2, MLH1, MSH6, PMS2, and EPCAM) have been associated with the hereditary cancer syndrome, the Lynch syndrome (LS). This evidence concerns the gene MLH1 and Inherited cancer-predisposing syndrome.